Photobiomodulation activates undifferentiated macrophages and promotes M1/M2 macrophage polarization via PI3K/AKT/mTOR signaling pathway
- PMID: 36932298
- DOI: 10.1007/s10103-023-03753-x
Photobiomodulation activates undifferentiated macrophages and promotes M1/M2 macrophage polarization via PI3K/AKT/mTOR signaling pathway
Abstract
Macrophages are the main mediators of the inflammatory response and play a major role in the onset and maintenance of periodontitis. Studies revealed that photobiomodulation (PBM) can change the polarization state of macrophages and inflammation reduction, although the cellular mechanisms are not fully elucidated. Here, the present study explored the effect of PBM (980 nm) on undifferentiated and M1-type macrophages and the underlying mechanism. RAW264.7 cells were exposed to laser irradiation under different laser parameters (0.5, 5.0, and 10.0 J/cm2) with or without LY294002 (an inhibitor of PI3K pathway). Then, confocal laser microscopy was used to observe cell differentiation; qPCR was performed to examine the gene expression and western blotting was used to detect the protein in the PI3K/AKT/mTOR pathway and activated macrophage markers. The obtained results revealed that 980 nm PBM increased the mRNA expression of iNOS, Il-10, Arg1, and Il-12 along with the inflammatory cytokines Tnfα, IL-1β, and Il-6 in M0-type macrophages in dose-dependent manner. More interestingly, PBM at 5 J/cm2 decreased the mRNA expression of iNOS, Il-12, Tnfα, IL-1β, and Il-6 and increased the expression of Arg1 and Il-10 by M1-type macrophages, along with the elevated expression of phosphorylation of AKT and mTOR. Moreover, PBM-induced M1-type macrophage polarization was significantly attenuated via LY294002 treatment. These suggest that 980 nm PBM could activate M0-type macrophages and increase M2/M1 ratio via the PI3K/AKT/mTOR pathway.
Keywords: Inflammatory; Macrophages; Periodontitis; Photobiomodulation; Polarization.
© 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Similar articles
-
Sema3A Drives Alternative Macrophage Activation in the Resolution of Periodontitis via PI3K/AKT/mTOR Signaling.Inflammation. 2023 Jun;46(3):876-891. doi: 10.1007/s10753-022-01777-z. Epub 2023 Jan 4. Inflammation. 2023. PMID: 36598593
-
SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages.PLoS One. 2013 Dec 20;8(12):e84009. doi: 10.1371/journal.pone.0084009. eCollection 2013. PLoS One. 2013. PMID: 24376781 Free PMC article.
-
Akt, mTOR and NF-κB pathway activation in Treponema pallidum stimulates M1 macrophages.Int Immunopharmacol. 2018 Jun;59:181-186. doi: 10.1016/j.intimp.2018.03.040. Epub 2018 Apr 12. Int Immunopharmacol. 2018. PMID: 29656208
-
Role of the PI3K/AKT (mTOR and GSK3β) signalling pathway and photobiomodulation in diabetic wound healing.Cytokine Growth Factor Rev. 2019 Dec;50:52-59. doi: 10.1016/j.cytogfr.2019.03.001. Epub 2019 Mar 12. Cytokine Growth Factor Rev. 2019. PMID: 30890300 Review.
-
Exploring the mechanism and crosstalk between IL-6 and IL- 1β on M2 macrophages under metabolic stress conditions.Cytokine. 2025 Feb;186:156852. doi: 10.1016/j.cyto.2024.156852. Epub 2025 Jan 6. Cytokine. 2025. PMID: 39765025 Review.
Cited by
-
Impact of Different Cell Types on the Osteogenic Differentiation Process of Mesenchymal Stem Cells.Stem Cells Int. 2025 Feb 13;2025:5551222. doi: 10.1155/sci/5551222. eCollection 2025. Stem Cells Int. 2025. PMID: 39980864 Free PMC article. Review.
-
In Vitro Effects of Low-Level Laser Therapy on the Viability and Secretory Activity of Resting Macrophages.Biomedicines. 2025 Feb 7;13(2):403. doi: 10.3390/biomedicines13020403. Biomedicines. 2025. PMID: 40002816 Free PMC article.
-
Phytic acid-based nanomedicine against mTOR represses lipogenesis and immune response for metabolic dysfunction-associated steatohepatitis therapy.Life Metab. 2024 Jun 18;3(6):loae026. doi: 10.1093/lifemeta/loae026. eCollection 2024 Dec. Life Metab. 2024. PMID: 39873005 Free PMC article.
-
Reprogramming Macrophage Phenotypes With Photobiomodulation for Improved Inflammation Control in ENT Organ Tissues.Clin Exp Otorhinolaryngol. 2025 Feb;18(1):1-13. doi: 10.21053/ceo.2024.00286. Epub 2024 Dec 19. Clin Exp Otorhinolaryngol. 2025. PMID: 39700888 Free PMC article.
-
mTOR Signaling in Macrophages: All Depends on the Context.Int J Mol Sci. 2025 Aug 6;26(15):7598. doi: 10.3390/ijms26157598. Int J Mol Sci. 2025. PMID: 40806725 Free PMC article. Review.
References
-
- Wu L, Zhang SQ, Zhao L, Ren ZH, Hu CY (2022) Global, regional, and national burden of periodontitis from 1990 to 2019: results from the Global Burden of Disease study 2019. J Periodontol 93(10):1445–1454. https://doi.org/10.1002/JPER.21-0469 - DOI - PubMed
-
- Luo LS, Luan HH, Jiang JF, Wu L, Li C, Leng WD, Zeng XT (2022) The spatial and temporal trends of severe periodontitis burden in Asia, 1990-2019: a population-based epidemiological study. J Periodontol 93(11):1615–1625. https://doi.org/10.1002/JPER.21-0625 - DOI - PubMed
-
- Lang NP, Bartold PM (2018) Periodontal health. J Clin Periodontol 45(Suppl 20):S9–S16. https://doi.org/10.1111/jcpe.12936 - DOI - PubMed
-
- Grossi SG, Genco RJ, Machtei EE, Ho AW, Koch G, Dunford R, Zambon JJ, Hausmann E (1995) Assessment of risk for periodontal disease. II. Risk indicators for alveoar bone loss. J Periodontol 66:23–29. https://doi.org/10.1902/jop.1995.66.1.23 - DOI - PubMed
-
- Hajishengallis G, Chavakis T (2000) Lambris JD (2020) Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 84:14–34. https://doi.org/10.1111/prd.12331 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous